Welcome to Markets Desk, your midday read on what's moving markets and why.
Crypto is taking a serious hit. Bitcoin has shed roughly twenty percent of its value since May, with Ethereum tracking similar losses and total crypto market capitalization down thirty-six percent over the past year to just over two trillion dollars. The Strategy fallout has rattled investor confidence, and there's no clear floor in sight yet.
Shifting to equities, healthcare is quietly becoming the trade of the moment. Shares of AbbVie, Eli Lilly, and Johnson and Johnson were all on track for all-time highs Friday, as investors rotate out of tech and into the biopharmaceutical space. It's a classic defensive pivot, but the conviction behind these moves looks genuine rather than merely cautious.
And on the semiconductor side, Qualcomm made a headline-grabbing move at its investor day, nearly doubling its fiscal twenty twenty-nine non-handset revenue target to roughly forty billion dollars. That's a direct bet on AI-driven diversification beyond smartphones, and it signals Qualcomm is positioning itself as infrastructure, not just a chipmaker for your pocket.
That's the tape. Markets Desk, signing off the floor.
